Back to MRK Stock Lookup

Merck (MRK) – Company Press Releases

Sep 2, 2014 09:00 AM EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology
Sep 2, 2014 09:00 AM EMD Serono and Massachusetts General Hospital Collaborate to Better Understand Systemic Lupus Erythematosus and Lupus Nephritis
Sep 2, 2014 08:30 AM Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab, the Company’s Investigational Anti-PD-1 Antibody, at ESMO 2014
Aug 28, 2014 08:00 AM Compact, Easy-to-Use Steritest™ Symbio Pumps from EMD Millipore Leverage Industry Leading Technology for Improved Sterility Testing
Aug 26, 2014 08:00 AM EMD Millipore Expands Biomanufacturing Sciences and Training Center in Japan and Announces Opening of New Location in Tokyo
Aug 26, 2014 08:00 AM Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Aug 15, 2014 09:00 AM Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal
Aug 14, 2014 09:00 AM Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
Aug 13, 2014 05:58 PM Merck Statement regarding Role of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults
Aug 13, 2014 04:49 PM FDA Approves BELSOMRA® (suvorexant) for the Treatment of Insomnia
Aug 6, 2014 03:13 PM Boston Millennia Partners Liquidity Events Realize More Than $100 Million of Value for its Limited Partners
Aug 5, 2014 01:00 PM Merck Publishes 2013 Global Corporate Responsibility Report
Aug 5, 2014 06:00 AM Merck Completes Tender Offer to Acquire Idenix
Jul 30, 2014 07:00 AM Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Municipal Water, Environmental Samples and Beverages
Jul 30, 2014 07:00 AM Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Liquids
Jul 29, 2014 06:56 AM Merck Announces Second-Quarter 2014 Financial Results
Jul 29, 2014 02:30 AM EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Jul 24, 2014 08:30 AM Merck Initiates Phase 3 Study of Letermovir, an Investigational Antiviral for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients
Jul 23, 2014 12:15 PM Merck Announces Fourth-Quarter 2014 Dividend
Jul 17, 2014 08:30 AM Merck's HIV Campaign, I Design, Partners with Music Industry Promoter and HIV Advocate Maria Davis and Positive Women's Network - USA to Encourage Women Living with HIV to be "Vocal" about t
Jul 8, 2014 09:00 AM EMD Serono Participates in Global Grants Program to Fund Scientific Innovation and Medical Education
Jul 1, 2014 09:00 AM EMD Serono Commits EUR 2 million to the Grant for Fertility Innovation (GFI) for 2014 /15
Jun 30, 2014 08:00 AM Merck Announces Data from Investigational Phase 3 Study on EMEND® (aprepitant) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Undergoing Emetogenic Chemotherapy
Jun 30, 2014 06:00 AM Merck’s Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Melanoma
Jun 30, 2014 06:00 AM MSD’s Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Melanoma
Jun 26, 2014 08:00 AM Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
Jun 24, 2014 07:30 AM EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
Jun 23, 2014 05:00 PM Merck to Hold Second-Quarter 2014 Sales and Earnings Conference Call on July 29
Jun 23, 2014 08:00 AM Merck Names Michael J. Holston as Future General Counsel; Will Succeed Bruce N. Kuhlik in July 2015
Jun 20, 2014 07:30 AM Merck Begins Tender Offer to Acquire Idenix
Jun 13, 2014 08:00 AM Merck Launches Global Patient Registry Supporting Expanded Commitment to Real-World Outcomes Research in Type 2 Diabetes
Jun 11, 2014 09:00 AM EMD Serono Launches Compassionate Corps Program to Reduce Cost of Fertility Treatment for Eligible Military Veterans and their Spouses
Jun 9, 2014 07:30 AM Merck to Acquire Idenix
Jun 6, 2014 08:00 AM Merck to Present New Clinical Data on JANUVIA® (Sitagliptin), Investigational Omarigliptin, and Real-World Data in Patients with Type 2 Diabetes at the 74th Scientific Sessions of the American Diabe
Jun 6, 2014 08:00 AM MSD to Present New Clinical Data on Sitagliptin, Investigational Omarigliptin, and Real-World Data in Patients with Type 2 Diabetes at the 74th Scientific Sessions of the American Diabetes Associatio
Jun 5, 2014 05:00 PM First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily Dosing Regimen of ISENTRESS® (raltegravir)

Back to MRK Stock Lookup